EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia

Mark Bustoros, Caitlin Gribbin, Jorge J Castillo, Richard Furman

Hematology/Oncology Clinics of North America · 2023

DOI: 10.1016/j.hoc.2023.06.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2023. Verfasst von Mark Bustoros und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA. Electr…. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Waldenström macroglobulinemia is an indolent IgM-secreting B-cell lymphoplasmacytic lymphoma that is preceded by an asymptomatic stage. Clinical and molecular features have been used in risk models to predict progression rates in different asymptomatic subgroups. Risk models used both disease-specific and nonspecific biomarkers for asymptomatic patients. Recently, models that incorporate continuous variables rather than distinct cutoffs have emerged to more accurately predict the risk of progression. Integrating genetic alterations to the clinical models is a promising approach that could improve risk stratification and management of asymptomatic patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waldenstrom MacroglobulinemiaBiomarkers, TumorHumansDisease ProgressionRisk AssessmentBiomarkersPrognosis

Stichwörter der Autor:innen

Asymptomatic WMMonoclonal gammopathy of undetermined significance (MGUS)Risk stratificationSmoldering WMWaldenström macroglobulinemia

Substanzen

Biomarkers, TumorBiomarkers

Autor:innen und Institutionen

  • Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA. Electronic address: mab4033@med.cornell.edu.
  • Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA.
  • Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

Zitieren

APA

Bustoros, M., Gribbin, C., Castillo, J. J., & Furman, R. (2023). Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2023.06.012

Vancouver

Bustoros M, Gribbin C, Castillo JJ, Furman R. Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. 2023. doi:10.1016/j.hoc.2023.06.012

BibTeX
@article{Bustoros2023,
  author = {Bustoros, Mark and Gribbin, Caitlin and Castillo, Jorge J and Furman, Richard},
  title = {Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2023},
  doi = {10.1016/j.hoc.2023.06.012}
}
Kostenlos starten →